Introduction and Objective: A novel fully autonomous microneedle array sensor providing semi-quantitative real-time glucose ranges expressed as three colors (Fig 1), activity and sleep data (Biolinq Incorporated, San Diego, CA) was developed to improve adherence in users with low numeracy burdened by CGM for safety and accuracy.Methods: A trial was conducted at 6 US sites […]
Read MoreMonth: June 2026
1306-OR: Longitudinal Impact of Remote Patient Monitoring on Glycemia Risk Index: A Duration–Response Analysis in a Real-World Cohort
Introduction and Objective: While the effect of remote patient monitoring (RPM) on diabetes is typically measured by A1C and TIR, these metrics obscure hypoglycemia and glucose excursions. The Glycemia Risk Index (GRI) is a validated composite metric that integrates both high- and low-glucose exposure to provide a comprehensive assessment of glycemic risk. The GRI stratifies […]
Read More1279-OR: Targeting Complex I-Reverse Electron Transport Protects against Palmitic Acid–Induced Endothelial Dysfunction
Introduction and Objective: Lipotoxicity causes diabetic vascular injury. While mitochondrial ROS (mtROS) are key, the role of complex I reverse electron transport (RET) is unclear. We aimed to define RET’s mechanistic role.Methods: We used palmitic acid (PA)-treated endothelial cells and high-fat diet (HFD)-fed mice. Assays included mtROS, NAD+/NADH, metabolism, and RNA-seq. RET was probed using […]
Read More1297-OR: Overdiagnosis of Prediabetes by GMI: Use of Updated GMI Improves Alignment with HbA1c and Time Above Range
Introduction and Objective: Glycemic Management Indicator (GMI) is a continuous glucose monitoring (CGM) metric increasingly used to identify prediabetes. However, alignment of this with laboratory glycated hemoglobin (HbA1c) and other CGM metrics varies, especially at lower glucose levels, risking overdiagnosis of prediabetes. We assessed HbA1c-GMI discordance and evaluated a physiological updated GMI (uGMI) for better […]
Read More1308-OR: Association of Randomization to Metformin with Prevalent Cognitive Impairment Syndromes in the Diabetes Prevention Program Outcomes Study
Introduction and Objective: Whether metformin affects dementia risk is unclear. We examined the association of randomized metformin (MET) vs placebo (PBO) and Intensive Lifestyle (ILS) interventions in the Diabetes Prevention Program (DPP) with cognitive impairment (CI) in the DPP Outcomes Study (DPPOS).Methods: Participants (n=1483, mean age 74 ± 8.4) were evaluated for prevalent CI in […]
Read MoreHealth Risks of Drinking Alcohol Escalate After 1 Drink a Day
Share on PinterestNew research found that health risks accelerate after 1 drink per day. Oleg Breslavtsev/Getty Images New research suggests alcohol-related health risks may begin at lower levels of drinking than previously thought. Researchers found no clear health benefit from even moderate alcohol consumption and concluded that both men and women should limit intake to […]
Read More1277-OR: Social Determinants of Health Score and Risk of Coronary Heart Disease in a Diverse Cohort of People with Type 2 Diabetes
Introduction and Objective: We examined the association between a composite social determinant of health (SDOH) score and incident coronary heart disease (CHD), adjusting for genetic susceptibility to CHD and traditional risk factors, among adults with T2D.Methods: We used data from 71,916 All of Us Research Program (AoU) participants with T2D who are free of CHD. […]
Read More1296-OR: Continuous Glucose Monitoring Metrics Are Associated with Diabetic Ketoacidosis across Pre-Event Time Windows
Introduction and Objective: While diabetic ketoacidosis (DKA) prediction models have been successfully developed using electronic health record (EHR) data, incorporating continuous glucose monitoring (CGM) metrics may further improve risk stratification. To explore this possibility, we examined the association between CGM metrics and DKA events in adults with type 1 diabetes (T1D).Methods: We identified adults with […]
Read More1332-OR: Identification of a Novel PKA Nuclear Translocation Pattern Driving Gluconeogenesis through TMEM201
Introduction and Objective: The protein kinase A (PKA) signaling cascade is the core signaling pathway of hepatic gluconeogenesis. However, the mechanisms governing PKA nuclear translocation remain incompletely understood. In this study, we identified the nuclear membrane protein TMEM201 (transmembrane protein 201) as a critical regulator of PKA nuclear translocation.Methods: PKA catalytic subunits were used as […]
Read More1286-OR: FiberMore: A Generative AI-Enabled Behavior Change Intervention to Improve Dietary Fiber Intake and Glycemic Management in Individuals with Type 2 Diabetes
Introduction and Objective: A high intake of dietary fiber has been shown to improve glycemic management in individuals living with Type 2 diabetes (T2D). We developed FiberMore, a generative AI-based mobile app grounded in the Theory of Planned Behavior, to address inadequate fiber intake in individuals with T2D, and assessed its efficacy in increasing fiber […]
Read More